S
301258
vs
S
Shanghai Composite
Over the past 12 months, Suzhou Fushilai Pharmaceutical Co Ltd has outperformed Shanghai Composite, delivering a return of +23% compared to the Shanghai Composite's +23% growth.
Stocks Performance
301258 vs Shanghai Composite
Performance Gap
301258 vs Shanghai Composite
Performance By Year
301258 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Suzhou Fushilai Pharmaceutical Co Ltd
Glance View
Suzhou Fushilai Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2022-03-29. Suzhou Fushilai Pharmaceutical Co Ltd is a China-based company mainly engaged in the production and sales of pharmaceuticals. The firm is mainly engaged in the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and raw materials for health care products. The firm's main products include three series of lipoic acid series, phosphatidylcholine series and carnosine series. The firm mainly conducts its business in domestic and overseas markets such as Europe, America, Japan and South Korea, India and South America.
